This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Maio, J J Articles by Brown, F L Search for Related Content PubMed PubMed Citation Articles by Maio, J J Articles by Brown, F L

 Previous Article  |  Next Article 

J Virol. 1988 April; 62(4): 1398-1407

Regulation of expression driven by human immunodeficiency virus type 1 and human T-cell leukemia virus type I long terminal repeats in pluripotential human embryonic cells.

Department of Cell Biology, Albert Einstein College of Medicine, Bronx, New York 10461.

ABSTRACT

Human pluripotential embryonic teratocarcinoma cells differentially expressed gene activity controlled by the human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type I (HTLV-I) long terminal repeats (LTRs) when differentiation was induced by the morphogen all-trans retinoic acid. The alterations occurred after commitment and before the appearance of the multiple cell types characteristic of these pluripotential cells. After commitment, gene activity controlled by the HIV-1 LTR markedly increased, whereas that controlled by the HTLV-I LTR decreased. Steady-state mRNA levels and nuclear run-on transcription indicated that the increased HIV-1-directed activity during differentiation occurred posttranscriptionally, whereas the decreased HTLV-I activity was at the transcriptional level. Phorbol esters did not cause commitment but strongly enhanced expression by both viral LTRs at the transcriptional level. A specific inhibitor of protein kinase C, 1-(5-isoquinolinylsulfonyl)-2-methylpiperazine, indicated that the enhanced activity involved the activation of protein kinase(s) C; altered cyclic nucleotide metabolism was apparently not involved. Differentiating cells gradually lost the ability to respond to phorbol ester stimulation. Experiments with a deletion mutant of the HIV-1 LTR suggested that this was due to imposition of negative regulation during differentiation that was not reversed by phorbol ester induction. Cycloheximide, with or without phorbol ester, slightly stimulated HIV-1-directed activity at the transcriptional level and massively increased the amounts of steady-state mRNA by posttranscriptional superinduction. It appeared, however, that new nuclear protein synthesis was required for maximal transcriptional stimulation by phorbol esters. Thus, changing cellular regulatory mechanisms influenced human retrovirus expression during human embryonic cell differentiation.

This article has been cited by other articles:

• Rolland, M., Jensen, M. A., Nickle, D. C., Yan, J., Learn, G. H., Heath, L., Weiner, D., Mullins, J. I. (2007). Reconstruction and Function of Ancestral Center-of-Tree Human Immunodeficiency Virus Type 1 Proteins. J. Virol. 81: 8507-8514 [Abstract] [Full Text]  
• Anderson, J. L., Johnson, A. T., Howard, J. L., Purcell, D. F. J. (2007). Both Linear and Discontinuous Ribosome Scanning Are Used for Translation Initiation from Bicistronic Human Immunodeficiency Virus Type 1 env mRNAs. J. Virol. 81: 4664-4676 [Abstract] [Full Text]  
• Daelemans, D., Schols, D., Witvrouw, M., Pannecouque, C., Hatse, S., van Dooren, S., Hamy, F., Klimkait, T., de Clercq, E., VanDamme, A.-M. (2000). A Second Target for the Peptoid Tat/Transactivation Response Element Inhibitor CGP64222: Inhibition of Human Immunodeficiency Virus Replication by Blocking CXC-Chemokine Receptor 4-Mediated Virus Entry. Mol. Pharmacol. 57: 116-124 [Abstract] [Full Text]  
• Oyama, T., Ran, S., Ishida, T., Nadaf, S., Kerr, L., Carbone, D. P., Gabrilovich, D. I. (1998). Vascular Endothelial Growth Factor Affects Dendritic Cell Maturation Through the Inhibition of Nuclear Factor-{kappa}B Activation in Hemopoietic Progenitor Cells. J. Immunol. 160: 1224-1232 [Abstract] [Full Text]  
• Daelemans, D., Esté, J. A., Witvrouw, M., Pannecouque, C., Jonckheere, H., Aquaro, S., Perno, C.-F., Clercq, E. D., Vandamme, A.-M. (1997). S-Adenosylhomocysteine Hydrolase Inhibitors Interfere with the Replication of Human Immunodeficiency Virus Type 1 through Inhibition of the LTR Transactivation. Mol. Pharmacol. 52: 1157-1163 [Abstract] [Full Text]  
• Lee, M.-O., Dawson, M. I., Picard, N., Hobbs, P. D., Pfahl, M. (1996). A Novel Class of Retinoid Antagonists and Their Mechanism of Action. J. Biol. Chem. 271: 11897-11903 [Abstract] [Full Text]